Abstract
Analysis of exosome information in bodily fluids is an important priority in liquid biopsy. Exosomal microRNAs (miRNAs) have been increasingly identified as credible objects due to their high stability and abundance. However, traditional detection techniques for exosomal miRNAs consume considerable time and require abundant professional equipment. Herein, we introduced a novel silica nanoquencher (qSiNP)-based nanoplatform with liposomal shell encapsulation. Liposomes were demonstrated to efficiently deliver qSiNPs into tumor exosomes via membrane fusion pathways. Subsequent loading of qSiNPs with fluorophore-labeled antisense oligonucleotides rapidly resulted in a specific fluorescent signal for “off-on” switchable in situ detection and imaging of targeted exosomal miRNAs without complicated RNA extraction or targeted amplification. With this strategy, the distinction of tumor-related miRNAs from normal exosomes was successfully achieved, which further indicated that our platform has the merits of easy preparation, stable encapsulation, efficient uptake, and an alterable molecular beacon, for improving the diagnostic value of liquid biopsy in various cancer diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
